340B Litigation After Genesis: Q&A Webinar - McDermott Will & Emery

340B Litigation After Genesis: Q&A Webinar


Join our experienced 340B team for an audience-led, open forum Q&A session to address the long-awaited Genesis HealthCare, Inc. v. Becerra decision. While the Genesis case is broadly viewed as a win for 340B-eligible providers, many questions remain, including:

  • How could the court’s opinion apply to entities other than Genesis?
  • How might 340B-eligible providers expand their 340B programs while remaining in compliance?
  • What does the court’s opinion mean about the Health Resources and Services Administration’s authority to interpret and enforce the 340B statute?

Earlier this month, a federal court in South Carolina issued a long-awaited decision in the case of Genesis HealthCare, Inc. v. Becerra. In its decision, the court stated that a 340B-eligible provider can obtain 340B drugs to fill a prescription from another provider, as long as the individual receiving the drugs is also a patient of the 340B-eligible provider.


November 28, 2023
1:00 – 2:00 pm EST


Dig Deeper

New York, NY / McDermott Event / October 17, 2024

Save the Date | HPE NYC 2024

London, United Kingdom / McDermott Event / September 19, 2024

HPE Europe 2024

Chicago, IL / Speaking Engagements / May 14, 2024

Modern Healthcare Digital Health Summit: Patients and Trust

Nashville, TN / McDermott Event / May 17, 2024

Value-Based Care Symposium 2024

Nashville, TN / McDermott Event / May 15-16, 2024

Physician Practice Management and ASC Symposium 2024

New York, NY / Speaking Engagements / May 10, 2024

19th Annual FCPA & Anti-Corruption for the Life Sciences Industry

Get In Touch